Invest in Denmark and Copenhagen Capacity have helped attract an important tuberculosis project to Denmark from the US based organisation, Aeras Global TB Vaccine Foundation. The first contact between Aeras and the two Danish organisations was established in New York in 2003, when representatives from Invest in Denmark and Copenhagen Capacity met the CEO of Aeras, Jerald Sadoff.
The project comprises two agreements. The first is between Aeras and Statens Serum Institut, a Danish state owned company engaged in prevention and control of infectious diseases, on development and production of a TB vaccine. The second is an agreement between Aeras and the Danish company Medicon. This project, which is supported financially by DANIDA, involves establishing clinical and educational infrastructure in South Africa to carry out TB vaccination programmes locally. Both agreements involve the creation of new jobs in Denmark.
Gitte Pedersen, Investment Manager for Invest in Denmark and Thomas Krarup, Business Development Manager for Copenhagen Capacity say: "In addition to putting a stop to TB spreading, the vaccine will also be vital to people who are HIV positive. Due to their weakened immune system, they have a much greater risk for developing TB than people who are not HIV positive."
The project will also bring Denmark into the world’s vaccine elite. The country already has significant competencies in both the private and public sector regarding research, development and production of vaccines.
"It has been a pleasure working with Aeras during the entire process," say Gitte Pedersen and Thomas Krarup. "We are very happy to have been able to contribute to bring a project of such a great importance to Denmark – a project with the potential to fight serious health problems in the third world."
For further information, please contact: Gitte Pedersen, Investment Manager, Invest in Denmark, E-mail: email@example.com
Mobile: +1 917 873 2003
Thomas Krarup, Business Development Manager, Copenhagen Capacity, E-mail: firstname.lastname@example.org
Mobile: +45 6162 6464